Loading clinical trials...
Loading clinical trials...
Investigators aimed to evaluate the effectiveness of exercise programs given by synchronous and asynchronous telerehabilitation methods in patients after discharge from COVID-19.
Fifty seven participants will be enrolled. Participants will be randomly divided into 3 groups. For this purpose, patients will be recruited at the time of discharge from the hospital and two experimental groups with the same physical therapy and educational program will be carried out. participants in the control group will only educational program. Participants in experimental groups will be followed using videoconference interviews from synchronous telerehabilitation methods and mobile application from asynchronous telerehabilitation methods at home. These participants will be given an 8-week exercise program. The exercise program will consist of physical exercises (aerobic and strength exercises) along with breathing exercises and the patients will be evaluated before and after the treatment. After treatment programs, the functional capacity, performance, and hemodynamic parameters of the participants will be evaluated. Quality of life, physical activity level, anxiety-depression, and fatigue severity will also be evaluated with questionnaires.
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
Marmara University
Maltepe, Istanbul, Turkey (Türkiye)
Start Date
September 25, 2021
Primary Completion Date
August 5, 2022
Completion Date
September 7, 2022
Last Updated
March 9, 2023
57
ACTUAL participants
Synchronous telerehabilitation programme
OTHER
Asynchronous telerehabilitation programme
OTHER
Lead Sponsor
Bitlis Eren University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06631287